{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:41:30Z","timestamp":1792219290024,"version":"4.4.0"},"reference-count":24,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Res &amp; Perspec"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Zastaprazan, a potassium\u2010competitive acid blocker, has been developed as an orally disintegrating tablet (ODT) to improve administration flexibility. This study evaluated the pharmacokinetics and safety of a single 20\u2009mg dose of Zastaprazan ODT administered with or without water compared with the conventional tablet in healthy volunteers. In this open\u2010label, randomized, single\u2010dose, 6\u2010sequence, 3\u2010period crossover study, 54 healthy volunteers received a conventional tablet with water, an ODT with water, and an ODT without water. Serial blood samples were collected up to 36\u2009h post\u2010dose, and pharmacokinetic parameters were calculated using a non\u2010compartmental method. Safety was assessed through adverse events, laboratory tests, vital signs, and electrocardiograms. Fifty\u2010one subjects completed all periods. The geometric mean ratios (90% confidence intervals) of\n                    <jats:italic>C<\/jats:italic>\n                    <jats:sub>max<\/jats:sub>\n                    and AUC\n                    <jats:sub>t<\/jats:sub>\n                    were 95.05% (88.38%\u2013102.21%) and 108.00% (100.50%\u2013116.06%) for ODT without water versus the conventional tablet, and 90.85% (84.96%\u201397.16%) and 101.88% (96.69%\u2013107.36%) for ODT with water versus the conventional tablet, respectively. All 90% confidence intervals were within the predefined bioequivalence range.\n                    <jats:italic>K<\/jats:italic>\n                    <jats:sub>a<\/jats:sub>\n                    and\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>max<\/jats:sub>\n                    showed similar patterns across treatments, and no apparent additional early systemic exposure was observed within 30\u2009min following ODT administration. Two mild adverse events were reported in one subject, with no serious adverse events. Zastaprazan ODT administered either with or without water was pharmacokinetically equivalent to the conventional tablet, with no apparent additional early systemic exposure and no clinically meaningful safety concerns.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Trial Registration:<\/jats:bold>\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                    : NCT07181538\n                  <\/jats:p>","DOI":"10.1002\/prp2.70337","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:00:12Z","timestamp":1792216812000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Pharmacokinetics and Safety of Orally Disintegrating and Conventional Tablet Formulations of Zastaprazan in Healthy Subjects"],"prefix":"10.1002","volume":"14","author":[{"given":"Hyung\u2010Gun","family":"Kim","sequence":"first","affiliation":[{"name":"Biomedical Research Institute, H+ Yangji Hospital  Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghyun","family":"Kang","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, H+ Yangji Hospital  Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunyoung","family":"Min","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, H+ Yangji Hospital  Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejoo","family":"Hong","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, H+ Yangji Hospital  Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7546-8301","authenticated-orcid":false,"given":"Moonjung","family":"Bae","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, H+ Yangji Hospital  Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2017.07.045","article-title":"Presentation and Epidemiology of Gastroesophageal Reflux Disease","volume":"154","author":"Richter J. E.","year":"2018","journal-title":"Gastroenterology"},{"key":"e_1_2_12_3_1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2036.2009.03960.x","article-title":"Systematic Review: The Global Incidence and Prevalence of Peptic Ulcer Disease","volume":"29","author":"Sung J. J. Y.","year":"2009","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"e_1_2_12_4_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease","volume":"117","author":"Katz P. O.","year":"2022","journal-title":"American Journal of Gastroenterology"},{"key":"e_1_2_12_5_1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12916-016-0718-z","article-title":"Effective and Safe Proton Pump Inhibitor Therapy in Acid\u2010Related Diseases: A Position Paper Addressing Benefits and Potential Harms of Acid Suppression","volume":"14","author":"Scarpignato C.","year":"2016","journal-title":"BMC Medicine"},{"key":"e_1_2_12_6_1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease","volume":"108","author":"Katz P. O.","year":"2013","journal-title":"American Journal of Gastroenterology"},{"key":"e_1_2_12_7_1","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.39","article-title":"Potassium\u2010Competitive Acid Blockers (P\u2010CABs): Are They Finally Ready for Prime Time in Acid\u2010Related Disease?","volume":"6","author":"Hunt R. H.","year":"2015","journal-title":"Clinical and Translational Gastroenterology"},{"key":"e_1_2_12_8_1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5056\/jnm18029","article-title":"Potent Potassium\u2010Competitive Acid Blockers: A New Era for the Treatment of Acid\u2010Related Diseases","volume":"24","author":"Oshima T.","year":"2018","journal-title":"Journal of Neurogastroenterology and Motility"},{"key":"e_1_2_12_9_1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1586\/ecp.09.33","article-title":"Long\u2010Lasting Inhibitors of the Gastric H, K\u2010ATPase","volume":"2","author":"Shin J. M.","year":"2009","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"e_1_2_12_10_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2016.08.001","article-title":"Potassium\u2010Competitive Acid Blockers: Advanced Therapeutic Option for Acid\u2010Related Diseases","volume":"168","author":"Inatomi N.","year":"2016","journal-title":"Pharmacology & Therapeutics"},{"key":"e_1_2_12_11_1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/apt.17406","article-title":"Randomised Clinical Trial: Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Zastaprazan (JP\u20101366), a Novel Potassium\u2010Competitive Acid Blocker, in Healthy Subjects","volume":"57","author":"Hwang I.","year":"2023","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"e_1_2_12_12_1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.14309\/ajg.0000000000002929","article-title":"Randomized, Double\u2010Blind, Active\u2010Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive Esophagitis","volume":"120","author":"Oh J. H.","year":"2025","journal-title":"American Journal of Gastroenterology"},{"key":"e_1_2_12_13_1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.5009\/gnl250334","article-title":"Randomized, Double\u2010Blind, Active\u2010Controlled, Parallel, Phase 3 Clinical Trial Evaluating the Efficacy and Safety of Zastaprazan in Patients With Gastric Ulcers","volume":"20","author":"Park K. S.","year":"2026","journal-title":"Gut and Liver"},{"key":"e_1_2_12_14_1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4314\/tjpr.v8i2.44525","article-title":"Orally Disintegrating Tablets: A Review","volume":"8","author":"Hirani J. J.","year":"2009","journal-title":"Tropical Journal of Pharmaceutical Research"},{"key":"e_1_2_12_15_1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1208\/s12249-008-9113-1","article-title":"A Novel Approach to Optimize and Formulate Fast Disintegrating Tablets for Nausea and Vomiting","volume":"9","author":"Goel H.","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"e_1_2_12_16_1","first-page":"4004","article-title":"A Review on Recent Trends in Oral Drug Delivery: Fast Dissolving Formulation Technology","volume":"11","author":"Lokhande P.","year":"2020","journal-title":"Journal of Current Pharmaceutical Research"},{"key":"e_1_2_12_17_1","first-page":"3212","article-title":"Orally Disintegrating Tablets: Recent Advancement in Formulation and New Market Opportunities","volume":"3","author":"Patil A. M.","year":"2012","journal-title":"Pharma Science Monitor"},{"key":"e_1_2_12_18_1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3390\/pharmaceutics16060799","article-title":"In Vitro Metabolism and Transport Characteristics of Zastaprazan","volume":"16","author":"Lee M. S.","year":"2024","journal-title":"Pharmaceutics"},{"key":"e_1_2_12_19_1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1701581","article-title":"Pharmacokinetics, Mass Balance, and Metabolism of the Novel Potassium\u2010Competitive Acid Blocker JP\u20101366 in Healthy Chinese Adults Following a Single Oral Dose of [14C] JP\u20101366","volume":"16","author":"Liu X.","year":"2025","journal-title":"Frontiers in Pharmacology"},{"key":"e_1_2_12_20_1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5414\/CP204378","article-title":"Evaluation of the Comparative Pharmacokinetic Properties of a New Orally Disintegrating Tablet of Tegoprazan in Healthy Korean Subjects","volume":"61","author":"Lee J. A.","year":"2023","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"e_1_2_12_21_1","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1111\/jgh.16017","article-title":"A Comparison of Efficacy and Safety of Potassium\u2010Competitive Acid Blocker and Proton Pump Inhibitor in Gastric Acid\u2010Related Diseases: A Systematic Review and Meta\u2010Analysis","volume":"37","author":"Simadibrata D. M.","year":"2022","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"e_1_2_12_22_1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/apt.18458","article-title":"Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro\u2010Oesophageal Reflux Disease or Erosive Oesophagitis","volume":"61","author":"Howden C. W.","year":"2025","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"e_1_2_12_23_1","article-title":"Comparative Efficacy and Safety of Tegoprazan Versus Proton Pump Inhibitors for Erosive Esophagitis: A Systematic Review and Meta\u2010Analysis","volume":"17","author":"Hussaini H.","year":"2025","journal-title":"Cureus"},{"key":"e_1_2_12_24_1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.otc.2024.02.013","article-title":"Dysphagia in Head and Neck Cancer","volume":"57","author":"Lakshmipathy D.","year":"2024","journal-title":"Otolaryngologic Clinics of North America"},{"key":"e_1_2_12_25_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2024.105728","article-title":"Dysphagia Development in Heart Failure Patients: A Scoping Review","volume":"130","author":"Suzuki M.","year":"2025","journal-title":"Archives of Gerontology and Geriatrics"}],"container-title":["Pharmacology Research &amp; Perspectives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.70337","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/prp2.70337","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.70337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:00:15Z","timestamp":1792216815000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/prp2.70337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10.1002\/prp2.70337"],"URL":"https:\/\/doi.org\/10.1002\/prp2.70337","archive":["Portico"],"relation":{},"ISSN":["2052-1707","2052-1707"],"issn-type":[{"value":"2052-1707","type":"print"},{"value":"2052-1707","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"2026-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70337"}}